Troy focuses on innovation strategy, transactions and new product commercialization to drive growth and value for life sciences companies and their investors. As leader of Locust Walk’s Strategy and Analytics practice, Troy advises clients on portfolio and partnering strategy. As Managing Director of Valamont Advisors, Troy acts as an independent business officer and strategy advisor. Having held senior positions in the life sciences practices of leading strategy consulting firms such as McKinsey, L.E.K. and EY-Parthenon, Troy has advised each of the top pharmaceutical and biotech companies, and more than 125 other therapeutic, diagnostic, medical device and digital health innovators. Troy was previously Vice President of Corporate Development for Biogen Idec, and earlier led Biogen's R&D investment prioritization process. Troy also led Business Development for three new ventures. He began his career with Astra USA where he led Clinical Operations, Finance and Planning. Troy received a BA in biochemistry from Harvard College and an MBA from Harvard Business School. Troy serves as an Innovation Fellow with Harvard Innovation Labs, as a member of MassBio’s Academic Initiatives Steering Committee, and a mentor to entrepreneur founders via HiLabs and MassConnect.